Innovative, centralised, multidisciplinary medicines optimisation clinic for PCSK9 inhibitors
Sign Up to like & getrecommendations! Published in 2022 at "Open Heart"
DOI: 10.1136/openhrt-2021-001931
Abstract: Background Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is) are an important but underutilised option to help optimise lipid management. We developed a new service to improve patient access to these medicines in line with National… read more here.
Keywords: pcsk9i therapy; optimisation; centralised multidisciplinary; optimisation clinic ... See more keywords